Hunton Andrews Kurth partner Armin Ghiam has entered an appearance for the Youth Fountain in a pending lawsuit. The case, filed Aug. 2 in New Jersey District Court by Gibbons and Covington & Burling on behalf of Novo Nordisk, maker of the type 2 diabetes and weight loss medications Wegovy, Ozempic and Rybelsus, is part of a string of cases accusing weight loss clinics, supplement companies and other defendants of misappropriating the plaintiff's marks to sell semaglutide-based compounded drugs for weight loss without FDA approval. The case, assigned to U.S. District Judge Michael A. Shipp, is 3:24-cv-08259, Novo Nordisk A/S et al v. The Youth Fountain LLC.
Biotech & Pharmaceuticals
August 13, 2024, 9:14 AM